| 35.085 -0.215 (-0.61%) | 12-15 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 44.64 | 1-year : | 52.14 |
| Resists | First : | 38.22 | Second : | 44.64 |
| Pivot price | 35.82  |
|||
| Supports | First : | 32.41 | Second : | 28.82 |
| MAs | MA(5) : | 35.99 |
MA(20) : | 34.55 |
| MA(100) : | 31.41 |
MA(250) : | 0 | |
| MACD | MACD : | 1.1  |
Signal : | 1.2 |
| %K %D | K(14,3) : | 55.6 |
D(3) : | 71.2 |
| RSI | RSI(14): 54.8 |
|||
| 52-week | High : | 55.63 | Low : | 23.9 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ AZTA ] has closed above bottom band by 30.4%. Bollinger Bands are 27.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 35.93 - 36.12 | 36.12 - 36.29 |
| Low: | 34.23 - 34.48 | 34.48 - 34.68 |
| Close: | 34.72 - 35.09 | 35.09 - 35.4 |
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
Sun, 14 Dec 2025
Is Azenta’s US$250 Million Buyback And M&A Push Altering The Investment Case For AZTA? - simplywall.st
Fri, 12 Dec 2025
Analysts Are Bullish on Top Healthcare Stocks: Azenta (AZTA), Boston Scientific (BSX) - The Globe and Mail
Fri, 12 Dec 2025
Natixis Takes Position in Azenta, Inc. $AZTA - MarketBeat
Wed, 10 Dec 2025
Azenta, Inc. Authorizes $250 Million Share Repurchase Program - TradingView — Track All Markets
Wed, 10 Dec 2025
Azenta Authorizes $250 Million Share Repurchase Program - PR Newswire
Wed, 10 Dec 2025
Azenta (AZTA) Schedules Investor Day for December - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 46 (M) |
| Shares Float | 41 (M) |
| Held by Insiders | 2 (%) |
| Held by Institutions | 110.9 (%) |
| Shares Short | 3,360 (K) |
| Shares Short P.Month | 3,110 (K) |
| EPS | 0.52 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 37.65 |
| Profit Margin | -9.4 % |
| Operating Margin | 1.1 % |
| Return on Assets (ttm) | -0.7 % |
| Return on Equity (ttm) | 1.3 % |
| Qtrly Rev. Growth | 5.1 % |
| Gross Profit (p.s.) | 5.87 |
| Sales Per Share | 12.91 |
| EBITDA (p.s.) | 0.86 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 72 (M) |
| Levered Free Cash Flow | 101 (M) |
| PE Ratio | 66.19 |
| PEG Ratio | 0 |
| Price to Book value | 0.93 |
| Price to Sales | 2.71 |
| Price to Cash Flow | 22.35 |
| Dividend | 0.1 |
| Forward Dividend | 0 |
| Dividend Yield | 0.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|